Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001474193 | SCV001678361 | likely benign | Immunodeficiency, common variable, 7 | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004037150 | SCV004851436 | uncertain significance | Inborn genetic diseases | 2023-09-22 | criteria provided, single submitter | clinical testing | The c.568G>A (p.V190I) alteration is located in exon 3 (coding exon 3) of the CR2 gene. This alteration results from a G to A substitution at nucleotide position 568, causing the valine (V) at amino acid position 190 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |